PEG-albumin Improves Survival in Severe Hemorrhagic Shock
Author Information
Author(s): Judith Martini, Pedro Cabrales, K Ananda, Seetharama A Acharya, Marcos Intaglietta, Amy G Tsai
Primary Institution: University of California, San Diego
Hypothesis
Does PEG-conjugated human serum albumin improve survival time compared to hydroxyethyl starch in severe hemorrhagic shock?
Conclusion
PEG-albumin significantly prolongs survival and maintains microvascular function better than HES during severe hemorrhagic shock.
Supporting Evidence
- All animals in the PEG-albumin group survived the protocol.
- None of the animals in the HES group survived the hemorrhage phase.
- PEG-albumin maintained higher functional capillary density compared to HES.
Takeaway
Using PEG-albumin instead of HES helps animals survive longer after a big blood loss during surgery.
Methodology
Hamster models were used to compare survival rates after hemodilution with PEG-albumin versus HES following a severe hemorrhage.
Limitations
The study was conducted in a small animal model, which may not fully represent human responses.
Participant Demographics
Male golden Syrian hamsters weighing 50 to 65 g.
Statistical Information
P-Value
0.003
Statistical Significance
p = 0.003
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website